Max is a founding partner at re.Mind, a venture capital fund focussed on mental & neurological health. The fund is the largest early-stage VC worldwide for investments exclusively focussed on the brain, and is closely affiliated with Christian Angermayer’s Apeiron Investment Group.

Prior to investing, Max was a strategy consultant for technology companies, and initially trained with McKinsey & Company. He holds a Masters in Mathematics.